Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)Bai-Yan Wang,Wan-Hong Zhao,Jie Liu,Yin-Xia Chen,Xing-Mei Cao,Yun Yang,Yi-Lin Zhang,Fang-Xia Wang,Peng-Yu Zhang,Bo Lei,Liu-Fang Gu,Jian-Li Wang,Jia-Jia Zhang,Ru Zhang,Hui Zhang,Ying Shen,Ju Bai,Yan Xu,Xu-Geng Wang,Rui-Li Zhang,Li-Li Wei,Zong-Fang Li,Gai-Xia He,Yan Geng,Qian He,Qiu-Chuan Zhuang,Frank Xiao-Hu Fan,Wang-Gang Zhang,Ai-Li HeBlood(2019)引用 73|浏览65关键词CAR T Cells,T Cell TherapyAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要